Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fusion Antibodies (FAB) Share Price

Price 15.50p on 29-08-2025 at 09:15:14
Change 0.75p 5.08%
Buy 16.00p
Sell 15.00p
Last Trade: Buy 10,000.00 at 15.68p
Day's Volume: 80,638
Last Close: 14.75p
Open: 14.75p
ISIN: GB00BDQZGK16
Day's Range 14.75p - 15.50p
52wk Range: 2.90p - 18.15p
Market Capitalisation: £17.62m
VWAP: 15.4305p
Shares in Issue: 113.66m

Fusion Antibodies (FAB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 10,000 15.68p Ordinary
10:15:07 - 29-Aug-25
Buy* 6,352 15.68p Ordinary
10:13:22 - 29-Aug-25
Buy* 31,585 15.80p Ordinary
09:29:54 - 29-Aug-25
Buy* 3 15.88p Ordinary
09:08:09 - 29-Aug-25
Buy* 799 16.00p SI Trade
08:55:37 - 29-Aug-25
Buy* 4 15.50p Ordinary
08:49:47 - 29-Aug-25
Sell* 429 14.683p Ordinary
08:47:18 - 29-Aug-25
Buy* 4 15.20p Ordinary
08:42:34 - 29-Aug-25
Buy* 4 15.20p Ordinary
08:28:42 - 29-Aug-25
Buy* 4 15.20p Ordinary
08:14:15 - 29-Aug-25
See more Fusion Antibodies trades

Fusion Antibodies (FAB) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Aug 2025 (Thu) 15.50 16.00 14.75 14.75 1,144,772
27th Aug 2025 (Wed) 15.25 16.50 14.75 14.75 1,125,706
26th Aug 2025 (Tue) 13.25 15.00 13.25 15.00 1,253,418
25th Aug 2025 (Mon) 13.25 13.25 13.25 13.25 0
22nd Aug 2025 (Fri) 14.00 14.25 13.25 13.25 1,375,315
21st Aug 2025 (Thu) 14.00 14.75 13.75 14.00 1,602,040
20th Aug 2025 (Wed) 15.00 15.00 13.25 14.00 1,655,816
19th Aug 2025 (Tue) 16.00 16.50 15.60 15.60 1,031,419
18th Aug 2025 (Mon) 17.25 18.15 15.50 16.00 1,838,934
15th Aug 2025 (Fri) 16.50 17.50 16.00 17.50 1,611,669
14th Aug 2025 (Thu) 15.75 17.00 16.50 17.00 1,400,659
13th Aug 2025 (Wed) 14.50 16.00 14.50 15.75 1,151,495
12th Aug 2025 (Tue) 13.75 15.25 13.75 14.50 1,220,736
11th Aug 2025 (Mon) 14.25 14.50 12.25 13.75 3,980,785
8th Aug 2025 (Fri) 14.50 15.00 14.00 14.00 5,581,917
7th Aug 2025 (Thu) 12.00 14.00 14.00 14.00 4,792,639
6th Aug 2025 (Wed) 10.75 12.00 10.75 12.00 2,433,748
5th Aug 2025 (Tue) 11.50 11.50 9.25 10.75 3,614,214
4th Aug 2025 (Mon) 11.00 11.00 10.50 10.50 1,884,773
1st Aug 2025 (Fri) 10.25 11.25 10.50 11.00 1,587,978
31st Jul 2025 (Thu) 10.50 10.50 10.25 10.25 751,527
30th Jul 2025 (Wed) 10.00 11.00 10.00 10.50 1,623,454
29th Jul 2025 (Tue) 9.75 10.75 9.75 10.00 2,806,755
See more Fusion Antibodies price history

Fusion Antibodies (FAB) Regulatory News

Date Source Headline
28th Aug 2025 7:00 am RNS Contract Win
27th Aug 2025 7:00 am RNS Contract wins with existing client
26th Aug 2025 7:00 am RNS-R Investor presentations
5th Aug 2025 7:00 am RNS Grant of U.S. Patent for OptiMAL
24th Jul 2025 10:56 am RNS Issue Notification: US Patent Update
11th Jul 2025 7:00 am RNS Director/PDMR Shareholding
2nd Jun 2025 7:00 am RNS Total Voting Rights
22nd May 2025 2:33 pm RNS Update on U.S. Patent for OptiMAL®
8th May 2025 7:00 am RNS-R Investor presentation
7th May 2025 7:00 am RNS Issue of shares to non-executive directors
See more Fusion Antibodies regulatory news

Fusion Antibodies (FAB) Share News

TRADING UPDATES: Avingtrans HS2 win; Metals Exploration's Runruno blow

28th Aug 2025 11:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Fusion Antibodies hails new contracts worth USD460,000

27th Aug 2025 14:24

(Alliance News) - Fusion Antibodies PLC on Wednesday said it was selected to proceed with three follow on projects to the stable Cell Line Development project. Read More

TRADING UPDATES: Poolbeg upsizes offer; Glenveagh backs outlook

22nd May 2025 22:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Fusion Antibodies receives approval of grant funding application

4th Dec 2024 12:18

(Alliance News) - Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Precision Biomarkers & Therapeutics consortium, of which it is a member. Read More

Fusion Antibodies interim loss narrows as revenue more than doubles

19th Nov 2024 13:10

(Alliance News) - Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue more than doubled. Read More

See more Fusion Antibodies news
FTSE 100 Latest
Value9,183.16
Change-33.66

Login to your account

Forgot Password?

Not Registered